|
2025
|
Invention
|
Methods of treating chronic graft versus host disease with belumosudil after ceasing administrati... |
|
2024
|
Invention
|
Anti-pd-1 antibodies and fusion proteins.
Provided herein are recombinant antibodies, antigen-bi... |
|
|
Invention
|
Methods of administering belumosudil in combination with transport protein substrates. The presen... |
|
|
Invention
|
Method of administering belumosudil for treatment of chronic graft versus host disease.
The pres... |
|
|
Invention
|
Combination therapy comprising btk inhibitor and belumosudil. Disclosed herein are methods of tre... |
|
|
Invention
|
Glucose uptake inhibitors.
This invention provides compounds that modulate glucose uptake activi... |
|
|
Invention
|
Methods of administering belumosudil in combination with cyp3a inducers and/or proton pump inhibi... |
|
|
Invention
|
Methods of administering belumosudil for treatment of chronic graft versus host disease in patien... |
|
|
Invention
|
Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease.
... |
|
|
Invention
|
Inhibitors of rho associated coiled-coil containing protein kinase.
The invention relates to inh... |
|
2023
|
Invention
|
Methods of administering belumosudil for treatment of multiple myeloma. The present disclosure pr... |
|
|
Invention
|
Solid dispersion comprising amorphous 2-[3-[4-(1h-indazol-5- ylamino)quinazolin-2-yl]phenoxy]-n-p... |
|
|
Invention
|
Method of administering belumosudil for patient subpopulations with hepatic impairment. The prese... |
|
|
Invention
|
Liquid formulation of belumosudil. The present disclosure provides liquid formulations comprising... |
|
|
Invention
|
Belumosudil for treating chronic lung allograft dysfunction.
The present disclosure relates gene... |
|
|
Invention
|
Methods of treating chronic graft-versus-host disease following allogeneic hematopoietic stem cel... |
|
|
Invention
|
Belumosudil for treating chronic lung allograft dysfunction. The present disclosure relates gener... |
|
|
Invention
|
Human anti-vegfr-2/kdr antibodies.
The invention relates to antibodies that bind to VEGFR-2. The... |
|
|
Invention
|
Methods of administering belumosudil for treatment of chronic graft versus host disease. The pres... |
|
|
Invention
|
Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease. T... |
|
2022
|
Invention
|
B7-h4 antibodies and anti-b7-h4 antibody/il-15 fusion proteins.
Provided herein are recombinant ... |
|
|
Invention
|
B7-h4 antibodies and anti-b7-h4 antibody/il-15 fusion proteins. Provided herein are recombinant a... |
|
|
Invention
|
Liquid formulation of belumosudil. The present disclosure provides a liquid formulation comprisin... |
|
|
Invention
|
Treatment of gvhd.
The invention relates to treatment of graft versus host disease (GVHD) using ... |
|
|
Invention
|
Use of dihydroorotate dehydrogenase (dhodh) inhibitors to target ferroptosis in cancer therapy.
... |
|
|
Invention
|
Use of dihydroorotate dehydrogenase (dhodh) inhibitors to target ferroptosis in cancer therapy. T... |
|
2021
|
Invention
|
Anti-pd-1 antibodies and fusion proteins. Provided herein are recombinant antibodies, antigen-bin... |
|
2020
|
P/S
|
Pharmaceuticals and pharmaceutical preparations for use in treating cancer, immunologic disorders... |
|
|
P/S
|
Pharmaceuticals for use in the fields of oncology,
immunology and viruses. |
|
|
Invention
|
Rho kinase inhibitors.
The invention relates to inhibitors of ROCK1 and/or ROCK2. Also provided ... |
|
|
Invention
|
Immunomodulatory agents.
The invention provides antibodies that specifically bind to PD-L1 and f... |
|
|
Invention
|
Human anti-vegfr-2/kdr antibodies. The invention relates to antibodies that bind to VEGFR-2. The ... |
|
2019
|
Invention
|
Glucose uptake inhibitors. This invention provides compounds that modulate glucose uptake activit... |
|
|
Invention
|
Glucose uptake inhibitors. Provided herein are compounds that modulate glucose uptake activity an... |
|
|
Invention
|
Rho kinase inhibitors. The invention relates to inhibitors of ROCK1 and/or ROCK2. Also provided a... |
|
2018
|
Invention
|
Inhibitors of rho associated coiled-coil containing protein kinase. The invention relates to inhi... |
|
|
Invention
|
Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors. This... |
|
2016
|
Invention
|
Treatment of infectious diseases with glucose uptake inhibitors. Provided are methods of treating... |
|
2010
|
P/S
|
Pharmaceuticals for use in the fields of oncology, immunology and viruses |
|
2005
|
P/S
|
Pharmaceutical preparation for the treatment of Hepatitis C |
|
2003
|
P/S
|
Pharmaceutical preparations for use, through prescription, in the treatment of chronic hepatitis C |
